Physician Investigator (Cl) Neurological Clinical Research Institute, Mass General Research Institute

Instructor in Neurology Harvard Medical School

Assistant In Neurology Massachusetts General Hospital

B.S. Stanford University 2011

MD Perelman School of Medicine at the Univeristy of Pennsylvania 2016

als biomarkers; amyotrophic lateral sclerosis Mark Garret is a neurologist and neuromuscular specialist focused on advancing clinical therapies for patients with amyotrophic lateral sclerosis (ALS). He leads the Dominantly Inherital ALS Network (DIALS), a longitudinal observational study following asymptomatic carriers of ALS disease causing gene variants that seeks to characterize the earliest detectable changes in ALS.  He is actively engaged in clinical trials of novel therapies for sporadic and familial forms of ALS